InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Buck Kristen K, Directeur R&D et Marketing. Director active across 2 companies, notably Caladrius Biosciences, INC.. In total, 13 filings have been logged. History available since 1 September 2021. The latest transaction was filed on 9 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Buck Kristen K is Director R&D and Marketing. She has 13 filings in total, and across the 13 most recent filings available, the recorded amounts are EUR 0 in buys and EUR 0 in sells, with filings ranging from 2021-09-03 to 2026-01-13. The most common transaction nature is Attribution, and the companies mentioned are LISATA THERAPEUTICS, INC. and Caladrius Biosciences, INC.